9th International Conference of Anticancer Research

International Institute of Anticancer Research
Last Modified: February 3, 2014

Dates: 6 -10 October 2014
Location: Sithonia, Halkidiki, Greece

Sponsoring Group: International Institute of Anticancer Research

Web Page URL: http://www.iiar-anticancer.org/conference/

Objectives: The purpose of the Anticancer Research Conferences is to exchange scientific information worldwide and to discuss recent advances in both broad and specialized areas of experimental and clinical cancer research. International Scientific and Medical Societies are invited to participate in the Conference by organizing specialized sessions. This initiative presents a forum for inter-Society communication allowing the organization and coordination of international activities on cancer. Special sessions will be devoted to the discussion and arrangement of international cooperation projects and activities, encompassing the aims of the International Institute of Anticancer Research. The Conference is organized and supported by the International Institute of Anticancer Research. The Scientific Program will comprise of oral (10, 15, 30 or 40 minutes) and poster presentations. Both overviews and original works will be presented. Each oral presentation will be allocated a five-minute discussion-time. Six conference rooms will be used simultaneously. Posters will be exhibited for 1-2 days. Projection facilities for PowerPoint presentations will be provided.

Who Should Attend: Oncologists, Biochemists, Medical Researchers

Agenda: Deadline for registration: September 26, 2014 Deadline for submission of abstracts: August 10, 2014 Arrivals: October 5, 2014 Departures: October 11, 2014

Fees: Registration fee: EURO 260.00; Students, EURO 140.00; Accompanying person, EURO 100.00 (each); Children, no fee.

Continuing Education: No

Audience: HCP

Blogs

In Celebration of Eric Ott
by Bob Riter
August 17, 2015

Related News

AACR: Conference Offers Look at Cancer Drugs in Pipeline

Aug 28, 2015

International conference presentations include leukemia drug screening, olaparib, cediranib


Circumcision May Cut Risk of Prostate Cancer

Jun 4, 2014

Greatest protective effect observed in men circumcised at age 36 years or older


May make possible earlier detection, treatment of these aggressive cancers

Sep 29, 2010

May make possible earlier detection, treatment of these aggressive cancers


Frequently Asked Questions